Market Exclusive

BEIGENE, LTD. (BGNE) Files An 8-K Other Events

BEIGENE, LTD. (BGNE) Files An 8-K Other Events

Item 8.01 Other Events.

On November11, 2016, BeiGene,Ltd. (the Company) issued a press
release announcing updated clinical data from its BGB-A317
clinical trial that was presented at the Society for
Immunotherapy of Cancer (SITC) 31st Annual Meeting held in
National Harbor, Maryland on November11, 2016.The full text of
the Companys press release is filed as Exhibit99.1 to this
Current Report on Form8-K and is incorporated herein by
reference.

Item9.01 Financial Statements and
Exhibits.

(d) Exhibits.

ExhibitNo.

Description

99.1

Press Release issued on November11, 2016

About BEIGENE, LTD. (BGNE)

Exit mobile version